Literature DB >> 3113643

IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease).

A Fornasieri, R A Sinico, P Maldifassi, P Bernasconi, M Vegni, G D'Amico.   

Abstract

Circulating IgA-antigliadin antibodies were detected with enzyme linked immunosorbent assay (ELISA) in four of 121 patients (3%) who had IgA mesangial nephropathy and 14 of 17 children (82%) who had untreated coeliac disease. No positive cases were present in the 54 healthy subjects of the control group. Three patients who had IgA nephropathy and IgA-antigliadin antibodies underwent jejunal biopsy, and two showed mucosal atrophy. In these two patients urinary abnormalities, together with the IgA-antigliadin antibodies, disappeared completely after three months and five months, respectively, of following a gluten free diet. Circulating IgA immune complexes were found in most patients who had coeliac disease and Berger's disease associated with IgA-antigliadin antibodies, suggesting overactivity of the B cells producing IgA in both conditions. By contrast, a circulating IgA rheumatoid factor was detectable in three of the four patients who had IgA nephropathy and asymptomatic coeliac disease but was always absent in children who had coeliac disease but did not show signs of renal disease. These results suggest that a more complex abnormality in the IgA immune response is necessary for renal disease to become manifest in patients who have gluten enteropathy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113643      PMCID: PMC1246960          DOI: 10.1136/bmj.295.6590.78

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  Gluten subfractions in coeliac disease.

Authors:  M J Kendall; R Schneider; P S Cox; C F Hawkins
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

2.  Detection and partial characterization of circulating immune complexes with solid-phase anti-C3.

Authors:  A B Pereira; A N Theofilopoulos; F J Dixon
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

3.  IgA anti-gliadin antibodies and jejunal mucosal lesions in healthy blood donors.

Authors:  J Hed; G Lieden; E Ottosson; M Ström; A Walan; O Groth; F Sjögren; L Franzen
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

4.  Immunologic studies in IgA nephropathy.

Authors:  A J Woodroffe; A A Gormly; P E McKenzie; A M Wootton; A J Thompson; A E Seymour; A R Clarkson
Journal:  Kidney Int       Date:  1980-09       Impact factor: 10.612

5.  T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis.

Authors:  J Egido; R Blasco; J Sancho; L Lozano
Journal:  Clin Immunol Immunopathol       Date:  1983-02

6.  IgA nephropathy associated with celiac disease and dermatitis herpetiformis.

Authors:  H Helin; J Mustonen; T Reunala; A Pasternack
Journal:  Arch Pathol Lab Med       Date:  1983-06       Impact factor: 5.534

7.  Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity.

Authors:  R Coppo; B Basolo; G Martina; C Rollino; M De Marchi; F Giacchino; G Mazzucco; M Messina; G Piccoli
Journal:  Clin Nephrol       Date:  1982-11       Impact factor: 0.975

8.  IgA-containing circulating immune complexes in patients with igA nephropathy.

Authors:  R P Hall; I Stachura; J Cason; T L Whiteside; T J Lawley
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

9.  Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis.

Authors:  J Egido; R Blasco; J Sancho; L Lozano; M Sanchez-Crespo; L Hernando
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

10.  Experimental IgA nephropathy induced by oral immunization.

Authors:  S N Emancipator; G R Gallo; M E Lamm
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Celiac disease: diagnostic criteria in progress.

Authors:  U Volta; V Villanacci
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

3.  Multiple immune disorders in unrecognized celiac disease: a case report.

Authors:  Giorgio La Villa; Pietro Pantaleo; Roberto Tarquini; Lino Cirami; Federico Perfetto; Francesco Mancuso; Giacomo Laffi
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

4.  Antigliadin antibody in an ataxic patient with no other evidence of celiac sprue.

Authors:  Brad E Maltz; Terrence A Smith
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

Review 5.  The investigation of haematuria.

Authors:  R H White
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

6.  Glomerular deposition of food antigens in IgA nephropathy.

Authors:  M Sato; H Kojima; K Takayama; S Koshikawa
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

7.  Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy?

Authors:  C Sategna-Guidetti; G Ferfoglia; M Bruno; R Pulitano; D Roccatello; A Amore; R Coppo
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

8.  Effects of neutral pepsin on the deposition of dietary antigens in glomeruli from IgA nephropathy.

Authors:  M Sato; H Kojima; K Kino; S Koshikawa
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

9.  Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders.

Authors:  C Sategna Guidetti; E Solerio; N Scaglione; G Aimo; G Mengozzi
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

10.  Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values.

Authors:  G Corrao; G R Corazza; M L Andreani; P Torchio; R A Valentini; G Galatola; D Quaglino; G Gasbarrini; F di Orio
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.